A

AbCellera Biologics

Antibody discovery and licensing platform

Research Scientist 1 - Pharmacokinetics

Translational Research & Bench BiologyConfirmed live in the last 24 hours
Full-timeVancouver, BC, CanadaCA$80k - CA$98k /yrIn-person

About the Job

Requirements

  • Strong understanding of antibody pharmacokinetics.
  • Hands-on experience with ligand-binding assays such as ELISA, MSD, or other plate-based assays.
  • A PhD in a related field, an MSc plus 3–5 years of experience in an academic or industry environment, or a BSc plus 5 or more years of related experience.
  • Experience with non-compartmental pharmacokinetic data analysis using WinNonlin is considered a strong asset.

Responsibilities

  • Generate bioanalytical and pharmacokinetic data from biological samples to critically assess therapeutic antibody programs.
  • Collaborate with cross-functional project teams as a representative of the pharmacokinetics function.
  • Define pharmacokinetic strategy to progress projects to the clinic, focusing on T-cell engagers.
  • Perform ELISA, MSD, and other bioanalytical assays on study samples efficiently and accurately.
  • Drive the development and implementation of innovative bioanalytical methods to support the pharmacokinetics research and development pipeline.
  • Collaborate with teammates to solve problems, analyze and interpret data, and communicate findings.

Desired Qualifications

  • Experience with non-compartmental pharmacokinetic data analysis using WinNonlin.

About the Company

AbCellera Biologics

Antibody discovery and licensing platform

AbCellera Biologics helps other companies and research teams find and develop antibody therapies. It uses a proprietary technology platform to identify antibody candidates and collaborates with pharmaceutical and biotech partners to accelerate drug discovery and development. The company's products are the antibody candidates and discovery services it provides under licensing or collaboration agreements, as well as its own internal therapeutic programs. Unlike many competitors, AbCellera emphasizes tackling difficult drug targets and building long-term partnerships with a wide range of clients, using data-driven, multidisciplinary approaches to speed up discovery. The goal is to deliver safe, effective antibody medicines to patients by advancing partner programs and its own pipeline through discovery, licensing, and development.

Company size
501-1,000
Company stage
IPO
Headquarters
Vancouver, Canada
Founded
2012

Recently Posted Jobs

Explore more opportunities at AbCellera Biologics

See more jobs